Compositions and methods for treating neurological disorders

Details for Australian Patent Application No. 2005259991 (hide)

Owner ID Biomedical Corporation of Quebec The Brigham and Women's Hospital, Inc.

Inventors Frenkel, Dan; Burt, David; Maron, Ruth; Weiner, Howard L.

Agent Davies Collison Cave

Pub. Number AU-B-2005259991

PCT Pub. Number WO2006/004749

Priority 60/582,999 25.06.04 US

Filing date 27 June 2005

Wipo publication date 12 January 2006

Acceptance publication date 26 May 2011

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/004749 Priority application(s): WO2006/004749

26 May 2011 Application Accepted

  Published as AU-B-2005259991

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259992-Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis

2005259987-Inverse emulsion polymer and method of use thereof